How effective is it to switch among atypical antipsychotics? A randomized, open-label study of algorithm-based antipsychotic treatment to symptomatic patients with schizophrenia in a real-world clinical setting

被引：0
|
作者：
Suzuki, T.
Uchida, H.
Watanabe, K.
Tanabe, A.
Tsunoda, K.
Nomura, K.
Niou, S.
Takeuchi, H.
Yagi, G.
Kashima, H.
机构：
[1] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[2] Inokashira Hosp, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S269 / S269
页数：1
相关论文
共 44 条
  • [31] Clinical usefulness of the Driver ® stent in a retrospective, collaborative, multicenter, open-label study in Japanese real-world patients with coronary artery disease and the drug-eluting stent era
    Nanto S.
    Awata M.
    Shimomura H.
    Hayashi T.
    Sonoda S.
    Ohashi Y.
    Iwasaki Y.
    Nakashima H.
    Cardiovascular Intervention and Therapeutics, 2011, 26 (2) : 131 - 137
  • [32] GnRH-a based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial
    Liu, Qian
    Cao, Dongyan
    Zhou, Huimei
    Yu, Mei
    Yang, Jiaxin
    Wang, Tao
    Wang, Yongxue
    Wang, Jinhui
    Peng, Peng
    Cheng, Ninghai
    Shen, Keng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A18 - A18
  • [33] GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol
    Qian Liu
    Huimei Zhou
    Mei Yu
    Dongyan Cao
    Jiaxin Yang
    Trials, 25 (1)
  • [34] How well do clinical and demographic characteristics predict Patient Health Questionnaire-9 scores among patients with treatment-resistant major depressive disorder in a real-world setting?
    Voelker, Jennifer
    Joshi, Kruti
    Daly, Ella
    Papademetriou, Eros
    Rotter, David
    Sheehan, John J.
    Kuvadia, Harsh
    Liu, Xing
    Dasgupta, Anandaroop
    Potluri, Ravi
    BRAIN AND BEHAVIOR, 2021, 11 (02):
  • [35] A randomized, open-label, multi-center phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy-based treatment strategy in patients with hormone receptor-positive, HER2-negative metastatic breast cancer in a real world setting (PADMA)
    Loibl, Sibylle
    Barinoff, Jana
    Seiler, Sabine
    Decker, Thomas
    Denkert, Carsten
    Hardy-Bessard, Anne-Claire
    Senkus-Konefka, Elzbieta
    Cognetti, Francesco
    Palmieri, Carlo
    Gelmon, Karen
    Luebbe, Kristina
    Furlanetto, Jenny
    Mueller, Volkmar
    Mundhenke, Christoph
    Schmidt, Marcus
    von Minckwitz, Gunter
    Uhlig, Mathias
    Burchardi, Nicole
    Thill, Marc
    CANCER RESEARCH, 2018, 78 (04)
  • [36] Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations
    Turkoz, Ibrahim
    Daskiran, Mehmet
    Siddiqui, Uzma
    Knight, R. Karl
    Johnston, Karen L.
    Correll, Christoph U.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2024, 27 (02):
  • [37] Effectiveness of Etanercept Biosimilar Initiating for Etanercept-Naive Patients, Using Ultrasound, Clinical, and Biomarker Assessments in Outcomes of Real-World Therapy (ENPORT-NGSK Study): An Interventional, Multicenter, Open-Label, Single-Arm Clinical Trial
    Sumiyoshi, Remi
    Kawashiri, Shin-ya
    Shimizu, Toshimasa
    Koga, Tomohiro
    Kiya, Rieko
    Tashiro, Shigeki
    Kawazoe, Yurika
    Sato, Shuntaro
    Ueki, Yukitaka
    Suzuki, Takahisa
    Yoshitama, Tamami
    Tada, Yoshifumi
    Hosogaya, Naoki
    Yamamoto, Hiroshi
    Kawakami, Atsushi
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (05)
  • [38] Real-world treatment patterns and clinical outcomes among patients with advanced melanoma A retrospective, community oncology-based cohort study (A STROBE-compliant article)
    Cowey, C. Lance
    Liu, Frank Xiaoqing
    Boyd, Marley
    Aguilar, Kathleen M.
    Krepler, Clemens
    MEDICINE, 2019, 98 (28)
  • [39] Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial
    Abe, Tomoe
    Takeda, Yasutaka
    Sakuma, Ichiro
    Okada, Mizuho
    Kurigaki, Ayaka
    Bessho, Ryoichi
    Sato, Mao
    Kitsunai, Hiroya
    Takiyama, Yumi
    Sakurai, Masaru
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (09) : 651 - 660
  • [40] Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naive human immunodeficiency virus-infected patients compared to non-nucleoside and protease inhibitor-based regimens in a real-world clinical setting A retrospective cohort study
    Jacobson, Karen
    Ogbuagu, Onyema
    MEDICINE, 2018, 97 (43)
12345